There’s something quite nice about having money deposited into your investment account quarter after quarter and 12 months after 12 months. Listed below are two outstanding dividend stocks with long histories of rewarding their shareholders with steadily rising money payments. Each stocks can assist you construct your personal streams of passive income.
Top dividend stock No. 1: Lockheed Martin
Lockheed Martin (NYSE: LMT) helps the U.S. government and its allies protect their residents from a growing variety of threats. The corporate is a crucial ally in an increasingly volatile world.
As a number one defense contractor, Lockheed supplies crucial technology to the U.S. military. Listed below are just a number of examples:
-
The F-35 stealth aircraft serves a vital role in the safety strategies of the Air Force, Navy, and Marines, in addition to that of 18 allied nations.
-
The Aegis radar system helps U.S. forces protect merchant shipping vessels from drone and missile attacks within the Red Sea.
-
Patriot-launched PAC-3 interceptors are enabling Ukraine to fend off Russia’s aerial bombardments.
Lockheed has amassed $159 billion value of orders for its broad array of defensive platforms. Combined with the long service lives of its key products — the F-35, for one, is anticipated to stay in service until a minimum of 2080 — this massive backlog gives investors a high degree of visibility into the corporate’s future money flow.
Management is committed to passing much of this money on to shareholders via stock buybacks and a steadily rising dividend. Over the past decade, Lockheed has bought back 1 / 4 of its shares, which has boosted per-share profits for its remaining stockholders. The defense leader has also raised its money payout for 21 straight years. Today, Lockheed’s dividend yield is a solid 2.7%.
Top dividend stock No. 2: Eli Lilly
For greater than 140 years, Eli Lilly (NYSE: LLY) has used cutting-edge science to assist people live higher. The healthcare leader’s history is chock-full of medical breakthroughs, but its latest discovery may very well be probably the most impactful and profitable one yet.
Almost 70% of American adults are obese or obese, which may result in life-threatening illnesses like diabetes, heart disease, and strokes. Fortunately, Eli Lilly has developed a game-changing drug that makes it easier for people to drop a few pounds.
Zepbound, the pharmaceutical pioneer’s weight-management treatment for adults, prompts hormone receptors that reduce appetite. Participants in a 72-week clinical trial who received the best dose of the drug lost 48 kilos on average.
When combined with weight loss plan and exercise, Zepbound also helped these people improve their cholesterol and blood pressure profiles. And tirzepatide, the lively ingredient in Zepbound, could make it easier for adults with type 2 diabetes to regulate their blood sugar levels. Higher still, recent studies suggest that tirzepatide could have positive effects for individuals with liver disease and sleep apnea.
As a consequence of tirzepatide’s many potential health advantages, CEO Dave Ricks believes it’s going to be a very powerful medicine of his 28-year profession. Wall Street seems to agree. Investment bank Goldman Sachs expects Eli Lilly to be a frontrunner in an anti-obesity drug market that may soar to $130 billion by the tip of the last decade. The corporate’s profits, in turn, are projected to extend by greater than 60% annually over the subsequent five years.
Do you have to invest $1,000 in Lockheed Martin immediately?
Before you purchase stock in Lockheed Martin, consider this:
The Motley Idiot Stock Advisor analyst team just identified what they imagine are the 10 best stocks for investors to purchase now… and Lockheed Martin wasn’t certainly one of them. The ten stocks that made the cut could produce monster returns in the approaching years.
Consider when Nvidia made this list on April 15, 2005… should you invested $1,000 on the time of our suggestion, you’d have $757,001!*
Stock Advisor provides investors with an easy-to-follow blueprint for fulfillment, including guidance on constructing a portfolio, regular updates from analysts, and two recent stock picks every month. The Stock Advisor service has greater than quadrupled the return of S&P 500 since 2002*.
*Stock Advisor returns as of June 24, 2024
Joe Tenebruso has no position in any of the stocks mentioned. The Motley Idiot has positions in and recommends Goldman Sachs Group. The Motley Idiot recommends Lockheed Martin. The Motley Idiot has a disclosure policy.
Want Many years of Passive Income? 2 Top Dividend Stocks to Buy Now and Hold Eternally. was originally published by The Motley Idiot